XML 64 R52.htm IDEA: XBRL DOCUMENT v3.25.1
Stockholders’ Equity (Deficit) (Details Narrative) - USD ($)
 12 Months Ended
Dec. 12, 2024
Dec. 12, 2024
Oct. 04, 2024
Sep. 13, 2024
Jan. 12, 2024
Dec. 29, 2023
Jun. 02, 2023
Jan. 19, 2023
Jan. 01, 2023
Jan. 02, 2022
Sep. 14, 2021
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Jul. 12, 2023
Jul. 11, 2023
Jul. 10, 2023
May 12, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]                                    
Common stock, shares authorized                       975,000,000 975,000,000   975,000,000 97,500,000    
Share based payment issued, value                       $ 2,423,560 $ 1,341,729          
Shares vested 12,500                                  
Shares issued                       43,220 55,604          
Sharebased compensation arrangement by sharebased payment award, options, grants in period, gross                       120,000 85,000          
Accrued bonus compensation                       $ 3,907,000 $ 710,000          
Contractual term 5 years                     1 year 8 months 12 days 2 years 4 months 24 days 3 years 3 months 18 days        
Shares vested 2,500                                  
Preferred Stock, Conversion Basis                       The Series V: (i) is non-convertible, (ii) has a 20% liquidation preference over the shares of common stock, (iii) is non-voting and (iv) has certain rights to dividends and distributions (at the discretion of the Board)            
Market cap vesting thresholds, value $ 50,000,000                                  
Number of restricted stock units, vested 220,052                     445,350 34,180          
2021 Equity Incentive Plan [Member]                                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                                    
Number of additional shares authorized                               12,000,000 7,000,000  
Series V Preferred Stock [Member]                                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                                    
Shares vested                       98,294            
Shares vested 342,082                                  
Restricted shares 38,242                                  
Preferred Stock, Conversion Basis                       The distribution of Series V shares was approved and completed on June 2, 2023 to shareholders as of the record date of May 12, 2023. The Series V: (i) is non-convertible, (ii) has a 20% liquidation preference over the shares of common stock, (iii) is non-voting and (iv) has certain rights to dividends and distributions (at the discretion of the Board)            
Preferred stock value                       $ 2,646,314 $ 2,563,938          
Number of shares restricted                       465,402 25,026          
Number of restricted stock units, vested 60,052                                  
Restricted Stock [Member]                                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                                    
Shares issued       32,429                            
Sharebased compensation arrangement by sharebased payment award, options, grants in period, gross       347,970                            
Contractual term 2 years                                  
Grants approved         50,000                          
Vest description         vest annually over a 5-year period (10,000 per year) with the first vesting date of December 31, 2024 and each subsequent vesting on the one-year anniversary of the first vesting date, subject to continued employment on each applicable vesting date. vest annually over a 5-year period (10,000 per year) with the first vesting date of December 31, 2024 and each subsequent vesting on the one-year anniversary of the first vesting date, subject to continued employment on each applicable vesting date.                        
Restricted Stock [Member] | Series V Preferred Stock [Member]                                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                                    
Number of shares restricted                       98,294            
Restricted Common Stock [Member]                                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                                    
Restricted shares                         12,500          
Number of restricted stock units granted and vested, value                         $ 59,000          
Unrestricted Stock [Member] | Series V Preferred Stock [Member]                                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                                    
Number of shares restricted                       367,108            
Restricted Stock Units (RSUs) One [Member]                                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                                    
Market cap vesting thresholds, value                 $ 50,000,000 $ 100,000,000                
Restricted Stock Units (RSUs) Two [Member]                                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                                    
Market cap vesting thresholds, value                 100,000,000 150,000,000                
Restricted Stock Units (RSUs) Three [Member]                                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                                    
Market cap vesting thresholds, value                 150,000,000 200,000,000                
Unrecognized compensation                 83,000                  
Restricted Stock Units (RSUs) Four [Member]                                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                                    
Market cap vesting thresholds, value                 $ 300,000,000 $ 400,000,000                
Unrestricted Common Stock [Member]                                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                                    
Number of restricted stock units, vested 65,026                                  
Unrestricted [Member]                                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                                    
Number of restricted stock units, vested 25,026 62,718                                
Common Stock [Member]                                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                                    
Share based payment issued, shares                       1,376,101 505,511          
Share based payment issued, value                       $ 1,375 $ 506          
Shares vested 45,479     380,399               270,794            
Issuance of restricted stock, value       $ 430,000                            
Sharebased compensation arrangement by sharebased payment award, options, grants in period, gross                       370,928 354,713          
Shares vested 342,082                                  
Restricted shares 38,242                                  
Issuance of common stock, net of offering cost / At-the-market offering, shares 296,603                     2,021,361 1,707,621          
Preferred Stock [Member] | Series V Preferred Stock [Member]                                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                                    
Share based payment issued, shares                       465,402 25,026          
Share based payment issued, value                       $ 82,376 $ 4,405          
Issuance of common stock, net of offering cost / At-the-market offering, shares             14,542,803                  
Preferred stock value                                   $ 2,560,000
Unrestricted Common Stock [Member]                                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                                    
Issuance of common stock, net of offering cost / At-the-market offering, shares 2,308                                  
Each Independent Director [Member]                                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                                    
Stock option grant date fair value               $ 50,000                    
Each Independent Director [Member] | Four Equal Installments [Member]                                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                                    
Stock option grant date fair value               $ 12,500                    
Independent Directors [Member]                                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                                    
Share based payment issued, shares                       87,498 122,124          
Share based payment issued, value                       $ 136,000 $ 150,000          
Officer [Member] | Common Stock [Member]                                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                                    
Share based compensation                       414,148 410,317          
Accrued bonus compensation                       $ 675,000 $ 264,000          
Mr. Allen [Member] | Restricted Stock [Member]                                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                                    
Grants approved           50,000                        
Mr. Handerhan [Member] | Restricted Stock [Member]                                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                                    
Grants approved           50,000                        
Mr Prevoznik [Member] | Restricted Stock [Member]                                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                                    
Grants approved         50,000 50,000                        
Mr. Paranjape [Member] | Restricted Stock [Member]                                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                                    
Grants approved         50,000 50,000                        
At-the-Market Offering Agreement [Member]                                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                                    
Gross proceeds from issuance of common stock     $ 250,000,000                 $ 6,905,000 $ 2,790,000          
Sale of stock, number of shares issued in transaction                       2,021,361 1,707,621          
Shares issued, price per share                       $ 3.42 $ 1.63          
Proceeds from issuance of stock net                       $ 6,682,000 $ 2,688,000          
At-the-Market Offering Agreement [Member] | H.C. Wainwright And Co LLC [Member]                                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                                    
Proceeds from issuance of common stock                     $ 98,767,500              
At-the-Market Offering Agreement [Member] | H.C. Wainwright and Co., LLC [Member]                                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                                    
Percentage of gross proceeds of offerings                     3.00%